CEL-SCI Corp Sustainability Reports

Cel-sci Corp. develops and commercializes innovative immunotherapy products for the treatment of cancer and infectious diseases as a publicly traded biotechnology company.

Sector: Health Care

Country: United States

Exchange: NYSE American

ISIN: US1508376076

4 reports from 2020 to 2025

    Company Profile

    CEL-SCI Corp

    Cel-sci Corp. develops and commercializes innovative immunotherapy products for the treatment of cancer and infectious diseases as a publicly traded biotechnology company.

    MIC

     

    Ticker

     

    ISIN

     

    Website

    www.cel-sci.com

    Country

    United States

    Exchange

    NYSE American

    Sector

    Health Care

    Industry

    Pharmaceuticals, Biotechnology & Life Sciences

    Reports

    Available reports